A long-term, trust-based CDMO partnership can support cell and gene therapy developers from early process development through ...
Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...
About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...
See how BioDlink’s digital-intelligence platform is driving three major improvements in lyophilization workflows.
Following the closure of Gujarat Kidney IPO, investor focus has now shifted to its allotment status. Gujarat Kidney IPO ...
GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...
Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...
Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...
Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...
Hamilton today announced the launch of GlucoSense, a breakthrough in bioprocess analytics that introduces the first reusable, in situ glucose sensor designed to deliver continuous, real-time ...
HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ('HYTN” or the 'Company”), a pharmaceutical-grade cannabis ...
KSH International is selling its shares in the price band of Rs 365-384, applied for a minimum of 39 shares and its multiples ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback